FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | Sample | Privacy
Related Topics >> counterfeit | Glaxosmithkline | G4S

In streamlining effort, GSK centralizes security

Free Newsletter

FiercePharma Manufacturing provides must-know news and insight on the hardware and software tools used to automate pharmaceutical manufacturing. Sign up today to receive your FREE "insiders only" weekly pharma manufacturing industry briefing.



Tools

GSK has gone global in its security approach. The drug giant has signed a five-year deal with security company G4S that is said to be among the first in which a large multinational drugmaker has opted to centralize security, rather than setting it up on a country-by-country basis.

The Financial Times reports pharma security needs extend beyond that of multinationals in many other industries. Counterfeiting, thefts and attacks by animal activists require additional security measures.

G4S will centrally manage GSK's security services from the U.K. The contract covers operations and training, standards compliance, and services tailored to each site.

The initial rollout involves deployment of G4S employees to GSK sites across Argentina, Costa Rica, the U.K., U.S., and Venezuela, as well as GSK headquarters in Brentford, U.K. The companies expect G4S to reach GSK sites in an additional 28 countries within 18 months.

- see the release
- here's the article

Related Articles:
Drugs among favorites of cargo thieves
Pharma meets cargo thieves head-on


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FiercePharma Manufacturing Email Newsletter:

More stories about counterfeit   Glaxosmithkline   G4S